SurgePays Inc.
1.66
0.05 (3.11%)
At close: Jan 15, 2025, 11:42 AM

SurgePays Statistics

Share Statistics

SurgePays has 20.16M shares outstanding. The number of shares has increased by 4.51% in one year.

Shares Outstanding 20.16M
Shares Change (YoY) n/a
Shares Change (QoQ) 2.11%
Owned by Institutions (%) n/a
Shares Floating 13.95M
Failed to Deliver (FTD) Shares 500
FTD / Avg. Volume 0.09%

Short Selling Information

The latest short interest is 392.32K, so 1.95% of the outstanding shares have been sold short.

Short Interest 392.32K
Short % of Shares Out 1.95%
Short % of Float 2.81%
Short Ratio (days to cover) 3.13

Valuation Ratios

The PE ratio is 4.46 and the forward PE ratio is -17.78.

PE Ratio 4.46
Forward PE -17.78
PS Ratio 0.67
Forward PS 0.2
PB Ratio 3.26
P/FCF Ratio 9.19
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

SurgePays Inc. has an Enterprise Value (EV) of 97.41M.

EV / Earnings 4.72
EV / Sales 0.71
EV / EBITDA 4.85
EV / EBIT 5.16
EV / FCF 9.74

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.18.

Current Ratio 2.63
Quick Ratio 1.91
Debt / Equity 0.18
Total Debt / Capitalization 15.15
Cash Flow / Debt 2.04
Interest Coverage 31.65

Financial Efficiency

Return on equity (ROE) is 0.73% and return on capital (ROIC) is 62.6%.

Return on Equity (ROE) 0.73%
Return on Assets (ROA) 0.49%
Return on Capital (ROIC) 62.6%
Revenue Per Employee 6.23M
Profits Per Employee 937.18K
Employee Count 22
Asset Turnover 3.27
Inventory Turnover 11.22

Taxes

Income Tax -2.27M
Effective Tax Rate -0.12

Stock Price Statistics

The stock price has increased by -77.04% in the last 52 weeks. The beta is 1.39, so SurgePays 's price volatility has been higher than the market average.

Beta 1.39
52-Week Price Change -77.04%
50-Day Moving Average 1.75
200-Day Moving Average 2.57
Relative Strength Index (RSI) 37.91
Average Volume (20 Days) 552.81K

Income Statement

In the last 12 months, SurgePays had revenue of 137.14M and earned 20.62M in profits. Earnings per share was 1.45.

Revenue 137.14M
Gross Profit 35.64M
Operating Income 18.87M
Net Income 20.62M
EBITDA 20.08M
EBIT 18.87M
Earnings Per Share (EPS) 1.45
Full Income Statement

Balance Sheet

The company has 14.62M in cash and 5.44M in debt, giving a net cash position of 9.18M.

Cash & Cash Equivalents 14.62M
Total Debt 5.44M
Net Cash 9.18M
Retained Earnings -15.19M
Total Assets 41.50M
Working Capital 28.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.29M and capital expenditures -281.30K, giving a free cash flow of 10.01M.

Operating Cash Flow 10.29M
Capital Expenditures -281.30K
Free Cash Flow 10.01M
FCF Per Share 0.7
Full Cash Flow Statement

Margins

Gross margin is 25.99%, with operating and profit margins of 13.76% and 15.03%.

Gross Margin 25.99%
Operating Margin 13.76%
Pretax Margin 13.4%
Profit Margin 15.03%
EBITDA Margin 14.64%
EBIT Margin 13.76%
FCF Margin 7.3%

Dividends & Yields

SURG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 90.62%
FCF Yield 31%
Dividend Details

Analyst Forecast

The average price target for SURG is $8.5, which is 431.2% higher than the current price. The consensus rating is "Buy".

Price Target $8.5
Price Target Difference 431.2%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Nov 2, 2021. It was a backward split with a ratio of 1:50.

Last Split Date Nov 2, 2021
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score 2.37
Piotroski F-Score 3